EP3458479
Mótefni gegn B7-H3 og lyfjaafleiður af mótefnum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.6.2017EP published:
4.11.2020EP application number:
17732657.6
EP translation filed:
2.2.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
6.6.2037Expiry date:
6.6.2026Next due date:
30.6.2026
Title:
ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Timeline
Today
7.6.2017EP application
4.11.2020EP Publication
2.2.2021Translation submitted
15.2.2021Registration published
6.6.2026Expires
Owner
Name:
AbbVie Inc.Address:
1 North Waukegan Road, North Chicago, IL 60064, US
Inventor
Name:
BENATUIL, LorenzoAddress:
Northborough MA 101532, US
Name:
BRUNCKO, MilanAddress:
Green Oaks IL 60048, US
Name:
CHAO, DebraAddress:
Fremont CA 94555, US
Name:
IZERADJENE, KamelAddress:
Gurnee IL 60031, US
Name:
JUDD, Andrew, S.Address:
Grayslake IL 60030, US
Name:
PHILLIPS, Andrew, C.Address:
Libertyville IL 60048, US
Name:
SOUERS, Andrew, J.Address:
Libertyville IL 60048, US
Name:
THAKUR, ArchanaAddress:
Pleasanton CA 94588, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662347476 PDate:
8.6.2016Country:
US
Number:
201662366511 PDate:
25.7.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 31/00, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 12.5.2021
Expires: 6.6.2022
Payer: Örn Þór slf.
Number: 6
Paid: 18.5.2022
Expires: 6.6.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 24.5.2023
Expires: 6.6.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.5.2024
Expires: 6.6.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 30.5.2025
Expires: 6.6.2026
Payer: Árnason Faktor ehf.